Invesco Ltd. Oncternal Therapeutics, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.7 - $1.56 $8,519 - $18,985	-12,170 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.37 - $2.43 $406 - $721	-297 Reduced 2.38%	12,170 $17,000
Q4 2021 Feb 14, 2022	SELL	$2.27 - $4.39 $3,271 - $6,325	-1,441 Reduced 10.36%	12,467 $28,000
Q3 2021 Nov 15, 2021	BUY	$3.37 - $4.76 $7,953 - $11,233	2,360 Added 20.44%	13,908 $58,000
Q2 2021 Aug 17, 2021	SELL	$4.75 - $9.39 $4.5 Million - $8.89 Million	-946,382 Reduced 98.79%	11,548 $55,000
Q1 2021 May 17, 2021	BUY	$4.59 - $9.04 $4.4 Million - $8.66 Million	957,930 New	957,930 $7.97 Million

362K

Ticker ONCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,517,200
Market Cap $63.8M
Description
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.